Cost or price of sequencing? Implications for economic evaluations in genomic medicine
- PMID: 34113006
- PMCID: PMC8487947
- DOI: 10.1038/s41436-021-01223-9
Cost or price of sequencing? Implications for economic evaluations in genomic medicine
Conflict of interest statement
COMPETING INTERESTS
The authors declare no competing interests.
Comment in
-
Correspondence on "cost or price of sequencing? implications for economic evaluations in genomic medicine" by Grosse and Gudgeon.Genet Med. 2022 Jan;24(1):251-252. doi: 10.1016/j.gim.2021.08.006. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906460 No abstract available.
References
-
- Yeung A et al.A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients. Genet. Med 22, 1986–1993 (2020). - PubMed
-
- Assasi N, Schwartz L, Tarride JE, Goeree R & Xie F Economic evaluations conducted for assessment of genetic testing technologies: a systematic review. Genet. Test. Mol. Biomarkers 16, 1322–1335 (2012). - PubMed
-
- Schwarze K, Buchanan J, Taylor JC & Wordsworth S Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet. Med 20, 1122–1130 (2018). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
